A Leap of Faith? Sanctioning Xenotransplant Clinical Trials.

Fovargue, Sara J. (2005) A Leap of Faith? Sanctioning Xenotransplant Clinical Trials. Liverpool Law Review, 26 (2). pp. 125-147. ISSN 1572-8625

Full text not available from this repository.


Introducing a new medical technique, procedure or drug to the public via clinical trials is risky at the best of times. When the trial involves a biotechnology which holds out the promise of prolonging, if not saving, life the push to move from the laboratory to clinical trials may be hard to resist. In this article I explore whether the regulatory scheme for clinical trials in the UK is able to accommodate developing technologies by considering how the current legal and ethical frameworks determine when a procedure such as xenotransplantation should proceed to trials. In particular, I discuss whether basing our regulatory schemes on the principles espoused in the Declaration of Helsinki offer sufficient protection to those who may be affected by xenotransplant trials – the recipient, their health-care workers, close contacts and, unusually, the wider public. I question whether it is possible for a technology to be approved for clinical trials when allowing such trials may benefit the individual but ultimately negatively impact on society as a whole.

Item Type: Journal Article
Journal or Publication Title: Liverpool Law Review
Uncontrolled Keywords: /dk/atira/pure/researchoutput/libraryofcongress/k1
Departments: Faculty of Arts & Social Sciences > Law School
ID Code: 20839
Deposited By: Dr Sara Fovargue
Deposited On: 03 Dec 2008 13:12
Refereed?: Yes
Published?: Published
Last Modified: 06 Aug 2019 00:41
URI: https://eprints.lancs.ac.uk/id/eprint/20839

Actions (login required)

View Item View Item